Funding · Company
Aeovian Pharmaceuticals, Inc.
Berkeley, CABiotech & Pharma
Aeovian Pharmaceuticals, Inc. of Berkeley, CA has disclosed $105M across 2 Form D offerings filed with the SEC between May 13, 2024 and Dec 22, 2025.
$105M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersBerkeley, CAIndustryBiotech & Pharma (Pharmaceuticals)SEC CIK0001710088Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →